Showing results (581-590 of 629) with videos related to
Sort By:
Pageof 63
BMJ Open|January 17, 2024
Role of vitamin D supplementation in modifying outcomes after surgery: a systematic review of randomised controlled trialsAkshay Patel, Edward J Caruana, James Hodson, et al.Human Genetics|July 31, 2024
Scalable approaches for generating, validating and incorporating data from high-throughput functional assays to improve clinical variant classificationSamskruthi Reddy Padigepati, David A Stafford, Christopher A Tan, et al.International Journal of Cancer|January 8, 2013
Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer riskMadeleine M A Tilanus-Linthorst, Hester F Lingsma, D Gareth Evans, et al.JMIR Diabetes|January 7, 2022
Comparison of Daily Routines Between Middle-aged and Older Participants With and Those Without Diabetes in the Electronic Framingham Heart Study: Cohort StudyYuankai Zhang, Chathurangi H Pathiravasan, Michael M Hammond, et al.Iscience|November 24, 2025
Interleukin-38 is a negative regulator of trained immunity-A retrospective multi-omics studyLisa U Teufel, Vasiliki Matzaraki, Lukas Folkman, et al.Clinical Chemistry|December 1, 2020
Circular RNA Sequencing of Maternal Platelets: A Novel Tool for the Identification of Pregnancy-Specific BiomarkersCees Oudejans, Vera Manders, Allerdien Visser, et al.BMJ Global Health|June 19, 2026
"It is not something you like to hear, but it is something you have to know". Community preferences for risk communication during pregnancy in the context of an emerging pathogen: a multicountry qualitative study with women in three ZIKV endemic countries who were pregnant during and following ZIKVMaría Consuelo Miranda Montoya, Claudia Milena Hormiga Sánchez, Ester Paiva Souto, et al.Breast Cancer Research and Treatment|August 24, 2010
Body weight and risk of breast cancer in BRCA1/2 mutation carriersPeggy Manders, Anouk Pijpe, Maartje J Hooning, et al.Journal of Clinical Immunology|December 21, 2023
OTULIN Haploinsufficiency-Related Fasciitis and Skin Necrosis Treated by TNF InhibitionRob J W Arts, Tristan J van der Linden, Caspar I van der Made, et al.Arthritis Research & Therapy|May 23, 2015
Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trialSofie H M Manders, Wietske Kievit, Eddy Adang, et al.Pageof 63